FOXD2 and glioblastoma: siRNA-induced suppression of FOXD2-AS1 (si-FOXD2-AS1) in human GBM cell lines, U251 and A172, is associated with hypermethylation of the MGMT promoter, resulting in decreased MGMT mRNA and protein levels.